Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceutical company committed to improving patient lives ...
Capital Market on MSN
Glenmark Pharma set to launch Ropivacaine Hydrochloride Injection in US
The company confirmed that its product is bioequivalent and therapeutically equivalent to the reference drug, Naropin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback